세계의 AI 활용 신경 재활 외골격 시장 보고서(2025년)
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Global Market Report 2025
상품코드 : 1877504
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,693,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,675,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,656,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 AI 활용 신경 재활 외골격 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 10억 4,000만 달러에서 2025년에는 12억 4,000만 달러에 달하고, CAGR 18.7%로 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 재활 로봇의 보급 확대, 환자의 이동 능력 향상에 대한 수요 증가, 기술계 기업과 의료계 기업 간의 연계 확대, 의료기기의 상호 운용성 향상, 저침습 재활 솔루션에 대한 수요 증가 등이 요인으로 생각됩니다.

AI 활용 신경 재활 외골격 시장 규모는 앞으로 수년간 급속한 성장이 예상됩니다. 2029년까지 24억 3,000만 달러에 달하고, CAGR은 18.4%가 될 전망입니다. 예측 기간 중 성장 요인으로는 의료용 로봇에 대한 투자 증가, 다양한 환자 요구에 대응하는 외골격 맞춤화, 재활 요법에 학제적 접근 채용, 개발 도상 지역에서의 이동성 솔루션 수요 증가, 비침습적 치료법에 대한 환자 선호 증가 등을 들 수 있습니다. 예측 기간의 주요 동향으로는 AI 구동형 외골격 제어 기술의 진전, 정밀한 동작을 실현하는 첨단 센서의 통합, 경량 외골격 설계의 혁신, 클라우드 기반의 재활 데이터의 도입, 맞춤형 치료 알고리즘의 진보 등을 들 수 있습니다.

신경질환의 발생률 상승은 향후 수년간 AI 활용 신경 재활 외골격 시장의 성장을 견인할 것으로 예측됩니다. 신경질환이란 뇌, 척수, 신경에 영향을 미치고, 운동 기능, 인지 기능, 감각 기능 및 기타 신체 기능에 장애를 초래하는 병태를 가리킵니다. 신경 질환의 세계적인 증가는 주로 노화로 인한 것입니다. 고령자는 뇌졸중, 치매, 파킨슨병 등의 질환에 걸리기 쉽고, 이들은 노화와 함께 발병률이 상승하는 경향이 있습니다. AI 활용 신경 재활 외골격은 실시간 모니터링과 각 환자의 특정 요구에 대한 지적 조정을 통해 운동 기능 개선, 회복 촉진, 운동 장애 보상을 실현하는 개별화된 적응형 요법을 제공함으로써 신경질환을 가진 개인을 지원합니다. 예를 들어 미국 비영리의료단체인 알츠하이머병협회에 따르면 65세 이상의 미국인 약 670만명이 알츠하이머형 치매를 앓고 있으며, 이 수는 2060년까지 1,380만명에 달할 것으로 예측되고 있습니다. 따라서 신경질환 증가는 AI 활용 신경 재활 외골격 시장의 성장을 가속하고 있습니다.

AI 활용 신경 재활 외골격 시장의 주요 기업은 이동성, 안정성, 재활성과를 향상시키기 위해 로봇 제어 시스템 등 혁신 기술의 통합을 중시하고 있습니다. 로봇 제어 시스템이란 로봇이나 외골격의 움직임을 조정 및 관리하는 기술로 정밀하고 안정적이고 적응성 있는 동작을 가능하게 함으로써 이용자가 안전하고 효율적으로 걷기, 서기, 일상생활 동작을 할 수 있도록 지원합니다. 예를 들어, 2025년 5월에는 프랑스에 본사를 둔 로보틱스 기업인 Wandercraft SAS가 AI 탑재형 개인 외골격의 임상시험을 미국에서 시작했습니다. 이 장비는 첨단 물리 AI와 로봇 제어 시스템을 통합하여 척수 손상, 뇌졸중 및 기타 이동 장애가 있는 개인이 다양한 지형에서 안전하게 일어나고, 걷고 이동할 수 있도록 지원합니다. 사용자의 동작에 실시간으로 지속적으로 적응함으로써 이동 능력, 안정성 및 재활 성과를 향상시킵니다. 조이스틱식 제어 시스템과 체중, 노면, 속도의 변화를 예측하는 지능형 알고리즘을 탑재한 이 외골격은 자립성을 높이는 동시에 장기적인 휠체어 사용에 따른 2차 건강 위험을 최소화합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

An AI-enhanced neurorehabilitation exoskeleton is a wearable robotic system designed to support and optimize motor recovery through intelligent, adaptive control. By leveraging advanced AI algorithms, the system continuously analyzes the user's movement patterns to provide personalized and precise assistance during therapy sessions. Through real-time feedback and dynamic adjustments, it facilitates efficient rehabilitation by improving coordination, muscle strength, and overall functional mobility over time.

The key components of artificial intelligence (AI)-enhanced neurorehabilitation exoskeletons include hardware, software, and services. Hardware encompasses the physical elements of the exoskeleton that enable safe, effective, and user-responsive assisted movement. These devices can be classified based on mobility type as either mobile or stationary and integrate various technologies, such as powered, passive, or hybrid systems. They are applied across multiple therapeutic domains, including stroke rehabilitation, spinal cord injury, traumatic brain injury, and multiple sclerosis. The main end-users of these exoskeletons include hospitals and clinics, rehabilitation centers, and home care settings, where they enhance recovery outcomes and promote patient independence.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market statistics, including artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry global market size, regional shares, competitors with the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market share, artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry. This artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market size has grown rapidly in recent years. It will grow from $1.04 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 18.7%. The growth during the historic period can be attributed to the growing adoption of rehabilitation robotics, the rising need for enhanced patient mobility, the expansion of collaborations between technology and healthcare companies, the improvement in medical device interoperability, and the increasing demand for minimally invasive rehabilitation solutions.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market size is expected to see rapid growth in the next few years. It will grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth during the forecast period can be attributed to increased investment in medical robotics, greater customization of exoskeleton devices to meet diverse patient needs, the adoption of interdisciplinary approaches in rehabilitation therapies, growing demand for mobility solutions in developing regions, and a rise in patient preference for non-invasive treatment options. Key trends in the forecast period include progress in AI-driven exoskeleton control, integration of advanced sensors for precise movement, innovation in lightweight exoskeleton design, incorporation of cloud-based rehabilitation data, and advancements in personalized therapy algorithms.

The rising incidence of neurological disorders is expected to drive the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market in the coming years. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to impairments in movement, cognition, sensation, or other bodily functions. The global increase in neurological disorders is largely attributed to an aging population, as older adults are more susceptible to conditions such as stroke, dementia, and Parkinson's disease, which tend to become more prevalent with age. Artificial intelligence (AI) enhanced neurorehabilitation exoskeletons assist individuals with neurological disorders by providing personalized, adaptive therapy that improves motor function, accelerates recovery, and compensates for movement impairments through real-time monitoring and intelligent adjustments to each patient's specific needs. For example, in March 2023, according to the Alzheimer's Association, a US-based nonprofit health organization, approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, and this number is projected to reach 13.8 million by 2060. Hence, the increasing incidence of neurological disorders is fueling the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market.

Major players in the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market are emphasizing the integration of innovative technologies such as robotic control systems to enhance mobility, stability, and rehabilitation outcomes. Robotic control systems are technologies that coordinate and manage the movements of a robot or exoskeleton, helping users walk, stand, and perform daily activities safely and efficiently by enabling precise, stable, and adaptive motion. For instance, in May 2025, Wandercraft SAS, a France-based robotics company, initiated clinical trials in the United States for its AI-powered personal exoskeleton. The device integrates advanced physical AI and robotic control systems to assist individuals with spinal cord injuries, stroke, and other mobility impairments in standing, walking, and navigating various surfaces safely. Continuously adapting to user movements in real time, it improves mobility, stability, and rehabilitation outcomes. Equipped with a joystick-based control system and intelligent algorithms that anticipate changes in weight, surface, and speed, the exoskeleton promotes greater independence while minimizing secondary health risks associated with long-term wheelchair use.

In July 2025, Moody Neurorehabilitation Institute Inc., a US-based healthcare organization, acquired Wandercraft SAS's Atalante X exoskeleton for an undisclosed amount. Through this acquisition, Moody Neurorehabilitation Institute Inc. aims to strengthen its rehabilitation capabilities by offering high-intensity, hands-free gait therapy, improving outcomes for patients with complex mobility challenges, including those recovering from traumatic brain injuries. Wandercraft SAS is a France-based medical robotics company that specializes in providing AI enhanced neurorehabilitation exoskeletons.

Major players in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market are Ottobock SE & Co. KGaA, Shanghai Fourier Intelligence Co. Ltd., Kinova Inc., Cyberdyne Inc., Hocoma AG, Myomo Inc., Neofect Co. Ltd., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., AlterG Inc., RENU ROBOTICS CORPORATION, ExoAtlet Global S.A., REEV Robotics, Bionik Laboratories Corp., Rex Bionics PLC, Wearable Robotics Srl, Gogoa Mobility Robots S.L., Technaid S.L., Bionic Yantra Pvt. Ltd., and MediTouch Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market in 2024. The regions covered in artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market consists of revenues earned by entities by providing services such as patient assessment services, therapy planning services, remote monitoring services, maintenance and support services, and rehabilitation consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market also includes sales of brain-computer interface (BCI)-controlled exoskeletons, occupational exoskeletons for healthcare workers, AI-integrated exoskeletons with advanced sensors, and modular and customizable exoskeleton systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Characteristics

3. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Trends And Strategies

4. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Growth Analysis And Strategic Analysis Framework

6. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Segmentation

7. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Regional And Country Analysis

8. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

9. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

10. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

11. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

12. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

13. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

14. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

15. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

16. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

17. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

18. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

19. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

20. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

21. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

22. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

23. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

24. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

25. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

26. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

27. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

28. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

29. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

30. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Landscape And Company Profiles

31. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Other Major And Innovative Companies

32. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

34. Recent Developments In The Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

35. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기